2.
Pre-treatment with the antidepressant paroxetine, in patients receiving the pro-inflammatory cytokine, interferon-alpha, for hepatitis C or malignant melanoma has been shown to dramatically reduce rates of depression during cytokine therapy?
See Soskin and Fava: Interferon model, p 414
3.
Following a first episode of major depression lasting less than two years, the estimated likelihood of another episode across the lifespan is approximately which of the following:
See Shelton and Hollon, Introduction, p 434